SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (785)10/27/2004 10:18:28 AM
From: scaram(o)uche  Read Replies (1) of 810
 
I'm impressed that the discontinuation arms diverged to the level of "statistical significance".

Haven't followed them since the days of oncolytic viruses, apart from reading PRs and following your thoughts. Had, as you may remember, a negative view of them in the old virus days.

So...... not that Bayer has even thought about it, but would Onyx management agree to a buyout at 40? 38? 42?

nn??

I understand that many are hurting. Stock has come back better than 50% from the year's high. But my informal reading of the PR from a base of ignorance re. competition (although I don't buy the SU-11248 fear mongering), has left me tempted.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News